Andrew J. Schwab, Director at Camp4 Therapeutics Corp (CAMP), sold 400,000 shares at $4.04 ($1.6M) on 2026-08-27, disclosed to the SEC on 2026-08-31.
Open-market sale of $1.6M CAMP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CAMP | SELL | 2026-08-26 | $45 | — | Filing → |
| CAMP | SELL | 2026-08-21 | $880K | — | Filing → |
| SKYE | SELL | 2026-08-20 | $140K | — | Filing → |